urapidil has been researched along with Bladder Disorder, Neurogenic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamanishi, T | 3 |
| Yasuda, K | 3 |
| Tojo, M | 1 |
| Hattori, T | 1 |
| Sakakibara, R | 1 |
| Shimazaki, J | 1 |
| Kawabe, K | 2 |
| Ohshima, H | 1 |
| Morita, T | 2 |
| Homma, Y | 1 |
2 trials available for urapidil and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
The effect of urapidil on neurogenic bladder: a placebo controlled double-blind study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; M | 1996 |
A multicenter placebo-controlled, double-blind trial of urapidil, an alpha-blocker, on neurogenic bladder dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Follow-Up | 1999 |
1 other study available for urapidil and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction.
Topics: Adrenergic alpha-Antagonists; Aged; Female; Humans; Male; Middle Aged; Nervous System Diseases; Pipe | 1994 |